Dimitri Lodygin

825 total citations
9 papers, 696 citations indexed

About

Dimitri Lodygin is a scholar working on Molecular Biology, Oncology and Biotechnology. According to data from OpenAlex, Dimitri Lodygin has authored 9 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Biotechnology. Recurrent topics in Dimitri Lodygin's work include Cancer therapeutics and mechanisms (3 papers), Cancer-related Molecular Pathways (3 papers) and Cancer Research and Treatments (3 papers). Dimitri Lodygin is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Cancer-related Molecular Pathways (3 papers) and Cancer Research and Treatments (3 papers). Dimitri Lodygin collaborates with scholars based in Germany, United States and Switzerland. Dimitri Lodygin's co-authors include Heiko Hermeking, Antje Menssen, Joachim Diebold, Alexey Epanchintsev, Christian A. Sander, Amir S. Yazdi, Thomas Herzinger, Julian C. Desmond, Paulette Mhawech and H. Phillip Koeffler and has published in prestigious journals such as Journal of Clinical Investigation, Cancer Research and Oncogene.

In The Last Decade

Dimitri Lodygin

9 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dimitri Lodygin Germany	8	560	126	87	75	52	9	696
Shigeru Daido Japan	9	577 1.0×	124 1.0×	160 1.8×	49 0.7×	50 1.0×	17	966
Sung‐Keum Seo South Korea	14	432 0.8×	124 1.0×	116 1.3×	44 0.6×	34 0.7×	17	602
Sun Mi Hong South Korea	13	391 0.7×	115 0.9×	139 1.6×	70 0.9×	14 0.3×	21	619
Luca Hegedüs Hungary	16	435 0.8×	124 1.0×	75 0.9×	37 0.5×	17 0.3×	35	601
You Fu Pan China	12	503 0.9×	116 0.9×	118 1.4×	46 0.6×	25 0.5×	21	735
Tatsuya Usui Japan	12	334 0.6×	111 0.9×	80 0.9×	47 0.6×	23 0.4×	19	506
José Luís Oliva Spain	15	425 0.8×	101 0.8×	95 1.1×	26 0.3×	58 1.1×	23	596
Yanying Huo United States	14	767 1.4×	224 1.8×	163 1.9×	71 0.9×	20 0.4×	27	946
Taekwon Son South Korea	14	364 0.7×	142 1.1×	106 1.2×	66 0.9×	16 0.3×	26	576
Jacint Boix Spain	14	383 0.7×	128 1.0×	51 0.6×	22 0.3×	41 0.8×	22	563

Countries citing papers authored by Dimitri Lodygin

Since Specialization

Citations

This map shows the geographic impact of Dimitri Lodygin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitri Lodygin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitri Lodygin more than expected).

Fields of papers citing papers by Dimitri Lodygin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimitri Lodygin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitri Lodygin. The network helps show where Dimitri Lodygin may publish in the future.

Co-authorship network of co-authors of Dimitri Lodygin

This figure shows the co-authorship network connecting the top 25 collaborators of Dimitri Lodygin. A scholar is included among the top collaborators of Dimitri Lodygin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimitri Lodygin. Dimitri Lodygin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Wolf, Insa M. A., Björn‐Philipp Diercks, Jan Kempski, et al.. (2015). Frontrunners of T cell activation: Initial, localized Ca ²⁺ signals mediated by NAADP and the type 1 ryanodine receptor. Science Signaling. 8(398). ra102–ra102. 60 indexed citations

2.

Zhang, Wei, Michael Bauer, Roland S. Croner, et al.. (2007). DNA Stool Test for Colorectal Cancer: Hypermethylation of the Secreted Frizzled-Related Protein-1 Gene. Diseases of the Colon & Rectum. 50(10). 1618–1627. 45 indexed citations

3.

Lodygin, Dimitri, Alexey Epanchintsev, Antje Menssen, Joachim Diebold, & Heiko Hermeking. (2005). Functional Epigenomics Identifies Genes Frequently Silenced in Prostate Cancer. Cancer Research. 65(10). 4218–4227. 247 indexed citations

4.

Lodygin, Dimitri, Joachim Diebold, & Heiko Hermeking. (2004). Prostate cancer is characterized by epigenetic silencing of 14-3-3σ expression. Oncogene. 23(56). 9034–9041. 70 indexed citations

5.

Mhawech, Paulette, Julian C. Desmond, H. Phillip Koeffler, et al.. (2004). Downregulation of 14-3-3σ in ovary, prostate and endometrial carcinomas is associated with CpG island methylation. Modern Pathology. 18(3). 340–348. 73 indexed citations

6.

Lodygin, Dimitri, Amir S. Yazdi, Christian A. Sander, Thomas Herzinger, & Heiko Hermeking. (2003). Analysis of 14-3-3σ expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma. Oncogene. 22(35). 5519–5524. 74 indexed citations

7.

Lodygin, Dimitri, Antje Menssen, & Heiko Hermeking. (2002). Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53-independent manner. Journal of Clinical Investigation. 110(11). 1717–1727. 59 indexed citations

8.

Lodygin, Dimitri, Antje Menssen, & Heiko Hermeking. (2002). Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53-independent manner. Journal of Clinical Investigation. 110(11). 1717–1727. 63 indexed citations

9.

Lodygin, Dimitri, Antje Menssen, & Heiko Hermeking. (2002). Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53-independent manner. Journal of Clinical Investigation. 110(11). 1717–1727. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact